Primecap Management Co. CA Raises Stock Position in CME Group Inc. (NASDAQ:CME)

Primecap Management Co. CA increased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,861,690 shares of the financial services provider's stock after purchasing an additional 58,647 shares during the period. Primecap Management Co. CA owned approximately 0.52% of CME Group worth $410,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Harbor Capital Advisors Inc. lifted its stake in shares of CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider's stock worth $1,723,000 after buying an additional 45 shares in the last quarter. CVA Family Office LLC raised its stake in CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider's stock worth $96,000 after purchasing an additional 46 shares during the period. Lester Murray Antman dba SimplyRich raised its stake in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider's stock worth $1,507,000 after purchasing an additional 50 shares during the period. Zions Bancorporation N.A. raised its stake in CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider's stock worth $338,000 after purchasing an additional 54 shares during the period. Finally, Quent Capital LLC raised its stake in shares of CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider's stock valued at $131,000 after acquiring an additional 55 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Down 0.7 %

Shares of CME opened at $228.00 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.74. The business's 50-day moving average price is $223.21 and its 200 day moving average price is $210.81. The stock has a market capitalization of $82.16 billion, a P/E ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.59 billion. During the same quarter in the previous year, the business posted $2.25 EPS. The firm's quarterly revenue was up 18.4% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group's dividend payout ratio is 48.37%.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company's stock, valued at $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a report on Thursday, July 25th. Citigroup upped their target price on shares of CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a report on Thursday, October 24th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a report on Thursday, July 25th. Royal Bank of Canada restated a "sector perform" rating and issued a $235.00 target price on shares of CME Group in a report on Thursday, October 24th. Finally, The Goldman Sachs Group upped their price target on shares of CME Group from $195.00 to $198.00 and gave the company a "sell" rating in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.